Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Epilepsy Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Epilepsy Drugsmarket, defines the market attractiveness level of Epilepsy Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Epilepsy Drugs industry, describes the types of Epilepsy Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Epilepsy Drugs market and the development prospects and opportunities of Epilepsy Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Epilepsy Drugs market in Chapter 13.
By Player:
Janssen Pharmaceuticals
Cephalon
Shire
Johnson & Johnson
Pfizer
Abbvie
UCB
Sanofi SA
Abbott Laboratories
GlaxoSmithKline Plc
Valeant Pharmaceuticals International
Eisai
F Hoffmann-La Roche
Novartis AG
Sunovion Pharmaceuticals
By Type:
First Generation
Second Generation
By End-User:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Epilepsy Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Epilepsy Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Epilepsy Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Epilepsy Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Epilepsy Drugs Market Analysis and Outlook to 2022
-
7.1 Global Epilepsy Drugs Consumption (2017-2022)
-
7.2 United States Epilepsy Drugs Consumption (2017-2022)
-
7.3 Europe Epilepsy Drugs Consumption (2017-2022)
-
7.4 China Epilepsy Drugs Consumption (2017-2022)
-
7.5 Japan Epilepsy Drugs Consumption (2017-2022)
-
7.6 India Epilepsy Drugs Consumption (2017-2022)
-
7.7 South Korea Epilepsy Drugs Consumption (2017-2022)
8 Region and Country-wise Epilepsy Drugs Market Analysis and Outlook to 2028
-
8.1 Global Epilepsy Drugs Consumption Forecast (2022-2028)
-
8.2 United States Epilepsy Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Epilepsy Drugs Consumption Forecast (2022-2028)
-
8.4 China Epilepsy Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Epilepsy Drugs Consumption Forecast (2022-2028)
-
8.6 India Epilepsy Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Epilepsy Drugs Consumption Forecast (2022-2028)
9 Global Epilepsy Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Epilepsy Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global First Generation Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Second Generation Consumption and Growth Rate (2017-2022)
-
9.2 Global Epilepsy Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Online Pharmacies Consumption and Growth Rate (2017-2022)
10 Global Epilepsy Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Epilepsy Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global First Generation Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Second Generation Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Epilepsy Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
11 Global Epilepsy Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Epilepsy Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Epilepsy Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Epilepsy Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Epilepsy Drugs Market Competitive Analysis
-
14.1 Janssen Pharmaceuticals
-
14.1.1 Janssen Pharmaceuticals Company Details
-
14.1.2 Janssen Pharmaceuticals Epilepsy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Janssen Pharmaceuticals Epilepsy Drugs Product and Service
-
14.2 Cephalon
-
14.2.1 Cephalon Company Details
-
14.2.2 Cephalon Epilepsy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Cephalon Epilepsy Drugs Product and Service
-
14.3 Shire
-
14.3.1 Shire Company Details
-
14.3.2 Shire Epilepsy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Shire Epilepsy Drugs Product and Service
-
14.4 Johnson & Johnson
-
14.4.1 Johnson & Johnson Company Details
-
14.4.2 Johnson & Johnson Epilepsy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Johnson & Johnson Epilepsy Drugs Product and Service
-
14.5 Pfizer
-
14.5.1 Pfizer Company Details
-
14.5.2 Pfizer Epilepsy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Pfizer Epilepsy Drugs Product and Service
-
14.6 Abbvie
-
14.6.1 Abbvie Company Details
-
14.6.2 Abbvie Epilepsy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Abbvie Epilepsy Drugs Product and Service
-
14.7 UCB
-
14.7.1 UCB Company Details
-
14.7.2 UCB Epilepsy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 UCB Epilepsy Drugs Product and Service
-
14.8 Sanofi SA
-
14.8.1 Sanofi SA Company Details
-
14.8.2 Sanofi SA Epilepsy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Sanofi SA Epilepsy Drugs Product and Service
-
14.9 Abbott Laboratories
-
14.9.1 Abbott Laboratories Company Details
-
14.9.2 Abbott Laboratories Epilepsy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Abbott Laboratories Epilepsy Drugs Product and Service
-
14.10 GlaxoSmithKline Plc
-
14.10.1 GlaxoSmithKline Plc Company Details
-
14.10.2 GlaxoSmithKline Plc Epilepsy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 GlaxoSmithKline Plc Epilepsy Drugs Product and Service
-
14.11 Valeant Pharmaceuticals International
-
14.11.1 Valeant Pharmaceuticals International Company Details
-
14.11.2 Valeant Pharmaceuticals International Epilepsy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Valeant Pharmaceuticals International Epilepsy Drugs Product and Service
-
14.12 Eisai
-
14.12.1 Eisai Company Details
-
14.12.2 Eisai Epilepsy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Eisai Epilepsy Drugs Product and Service
-
14.13 F Hoffmann-La Roche
-
14.13.1 F Hoffmann-La Roche Company Details
-
14.13.2 F Hoffmann-La Roche Epilepsy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 F Hoffmann-La Roche Epilepsy Drugs Product and Service
-
14.14 Novartis AG
-
14.14.1 Novartis AG Company Details
-
14.14.2 Novartis AG Epilepsy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 Novartis AG Epilepsy Drugs Product and Service
-
14.15 Sunovion Pharmaceuticals
-
14.15.1 Sunovion Pharmaceuticals Company Details
-
14.15.2 Sunovion Pharmaceuticals Epilepsy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.15.3 Sunovion Pharmaceuticals Epilepsy Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Epilepsy Drugs
-
Figure Epilepsy Drugs Picture
-
Table Global Epilepsy Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Epilepsy Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Epilepsy Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Epilepsy Drugs Consumption by Country (2017-2022)
-
Figure United States Epilepsy Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Epilepsy Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Epilepsy Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Epilepsy Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Epilepsy Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Epilepsy Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Epilepsy Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Epilepsy Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Epilepsy Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Epilepsy Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Epilepsy Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Epilepsy Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Epilepsy Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global First Generation Consumption and Growth Rate (2017-2022)
-
Figure Global Second Generation Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Online Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global First Generation Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Second Generation Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Epilepsy Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Epilepsy Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Janssen Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Janssen Pharmaceuticals Epilepsy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Janssen Pharmaceuticals Epilepsy Drugs Product and Service
-
Table Cephalon (Foundation Year, Company Profile and etc.)
-
Table Cephalon Epilepsy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cephalon Epilepsy Drugs Product and Service
-
Table Shire (Foundation Year, Company Profile and etc.)
-
Table Shire Epilepsy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shire Epilepsy Drugs Product and Service
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Epilepsy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Epilepsy Drugs Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Epilepsy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Epilepsy Drugs Product and Service
-
Table Abbvie (Foundation Year, Company Profile and etc.)
-
Table Abbvie Epilepsy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbvie Epilepsy Drugs Product and Service
-
Table UCB (Foundation Year, Company Profile and etc.)
-
Table UCB Epilepsy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table UCB Epilepsy Drugs Product and Service
-
Table Sanofi SA (Foundation Year, Company Profile and etc.)
-
Table Sanofi SA Epilepsy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi SA Epilepsy Drugs Product and Service
-
Table Abbott Laboratories (Foundation Year, Company Profile and etc.)
-
Table Abbott Laboratories Epilepsy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Laboratories Epilepsy Drugs Product and Service
-
Table GlaxoSmithKline Plc (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Plc Epilepsy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Plc Epilepsy Drugs Product and Service
-
Table Valeant Pharmaceuticals International (Foundation Year, Company Profile and etc.)
-
Table Valeant Pharmaceuticals International Epilepsy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Valeant Pharmaceuticals International Epilepsy Drugs Product and Service
-
Table Eisai (Foundation Year, Company Profile and etc.)
-
Table Eisai Epilepsy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eisai Epilepsy Drugs Product and Service
-
Table F Hoffmann-La Roche (Foundation Year, Company Profile and etc.)
-
Table F Hoffmann-La Roche Epilepsy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffmann-La Roche Epilepsy Drugs Product and Service
-
Table Novartis AG (Foundation Year, Company Profile and etc.)
-
Table Novartis AG Epilepsy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG Epilepsy Drugs Product and Service
-
Table Sunovion Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Sunovion Pharmaceuticals Epilepsy Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sunovion Pharmaceuticals Epilepsy Drugs Product and Service
-
